Adicet follows other cell therapy biotechs in autoimmune pivot

Adicet Bio is shelv­ing plans to use its lead as­set to treat can­cer and in­stead shift­ing its tar­get to au­toim­mune dis­eases.

The move, dis­closed by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.